Dunn S J, Park S W, Sharma V, Raghu G, Simone J M, Tavassoli R, Young L M, Ortega M A, Pan C H, Alegre G J, Roninson I B, Lipkina G, Dayn A, Holzmayer T A
Ingenex Inc, Menlo Park, CA, USA.
Gene Ther. 1999 Jan;6(1):130-7. doi: 10.1038/sj.gt.3300791.
The development of general approaches for the isolation of efficient antivirals and the identification and validation of targets for drug screening are becoming increasingly important, due to the emergence of previously unrecognized viral diseases. The genetic suppressor element (GSE) technology is an approach based on the functional expression selection of efficient genetic inhibitors from random fragment libraries derived from a gene or genome of interest. We have applied this technology to isolate potent genetic inhibitors against HIV-1. Two strategies were used to select for GSEs that interfere with latent virus induction and productive HIV-1 infection based on the expression of intracellular and surface antigens. The selected GSEs clustered in seven narrowly defined regions of the HIV-1 genome and were found to be functionally active. These elements are potential candidates for the gene therapy of AIDS. The developed approaches can be applied to other viral pathogens, as well as for the identification of cellular genes supporting the HIV-1 life cycle.
由于此前未被认识的病毒性疾病不断出现,开发分离高效抗病毒药物的通用方法以及药物筛选靶点的鉴定和验证变得越来越重要。遗传抑制元件(GSE)技术是一种基于从感兴趣的基因或基因组衍生的随机片段文库中进行有效遗传抑制剂功能表达选择的方法。我们已应用该技术分离针对HIV-1的强效遗传抑制剂。基于细胞内和表面抗原的表达,采用了两种策略来选择干扰潜伏病毒诱导和HIV-1有效感染的GSE。所选的GSE聚集在HIV-1基因组的七个狭义定义区域,并且被发现具有功能活性。这些元件是艾滋病基因治疗的潜在候选者。所开发的方法可应用于其他病毒病原体,以及用于鉴定支持HIV-1生命周期的细胞基因。